by Luca Remotti | Jul 30, 2025 | Cardiovascular disease, Data Catalogue, Data integration tools, Federated Learning, metadata and semantic descriptions, semantic tooling
NextGen aims to develop tools for advance diagnostics, prediction and personalised medicine for cardiovascular disease, using sensitive data and information located at multiple sites. The sensitive nature of these data requires tools that search for multimodal...
by Luca Remotti | Jul 1, 2025 | Variant Prioritisation Acceleration, A prototype of a European Health Data Space in Cardiovascular Disease management, Cardiovascular disease
Genomic sequencing reveals the full DNA sequence of an individual, uncovering millions of genetic variants—small differences in the nucleotide sequence that make each person unique. Among these, some variants occur in genes or regulatory regions and may influence...
by Luca Remotti | Jun 5, 2025 | AI and ML supported genomic data curation, AI/ML Driven Tools Development, Cardiovascular disease, genomic data curation
Genome curation involves a series of steps that integrate genomic data with validated experimental evidence and literature from diverse databases. Effective data curation and quality control are essential to ensure the accuracy, consistency, and reliability of genomic...
by Luca Remotti | May 2, 2025 | Cardiovascular disease, A prototype of a European Health Data Space in Cardiovascular Disease management, AI/ML Driven Tools Development, Data integration tools, genetics, Personal Data Protection, Sensitive Data Protection
NextGen is a Horizon Europe research initiative, co-funded by UKRI (United Kingdom) and SERI (Switzerland) that develops multimodal, multiomic data integration, i.e. and federated analytics in personalised cardiovascular medicine....
by Luca Remotti | Mar 11, 2025 | artificial intelligence, AI/ML Driven Tools Development, Cardiovascular disease, Genomic Penetrance, Translational Vascular Medicine
Our NextGen project is actively participating in the DIA Europe 2025 annual meeting, taking place from 18 to 20 March 2025 in Basel, Switzerland. DIA Global – Drug Information Organisation is partner in the NextGen project and the leading global...
by admin | Feb 12, 2024 | artificial intelligence, Artificial Intelligence (Machine Learning, Deep Learning), Cardiovascular disease, Cardiovascular Disease in Primary Care, genetics
12 Feb 2024 Sophia Antipolis, 12 February 2024: An innovative project using artificial intelligence (AI) to personalise therapies for patients with cardiovascular disease has kicked off at a meeting in Utrecht, the Netherlands. The NextGen project has received...